Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease
1 clinical trials · Condition
◉ Watch Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease
| Record | Firm | Date |
|---|---|---|
| Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS) (NCT06052618) | National Cancer Institute (NCI) | 2025-03-17 |
Track Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease automatically
Every clearance here is in the API, with alerts when new ones post.